Atopaxar

DB12046InvestigationalSmall molecule

Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.

Mechanism: Pharmacologically active on Proteinase-activated receptor 1
Curator reviewed
Formula / weight: C₂₉H₃₈FN₃O₅ · 527.637 g/mol (avg)
Code names: E-5555 · ER-172594-00

Resolves to

Compound

Structure

InChIKeyQWKAUGRRIXBIPO-UHFFFAOYSA-NSMILESCCOC1=CC2=C(C(=N)N(CC(=O)C3=CC(=C(OC)C(=C3)N3CCOCC3)C(C)(C)C)C2)C(F)=C1OCC

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Atopaxar, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.